Philip James Wealth Mangement’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.24M Sell
8,948
-103
-1% -$35.3K 0.36% 56
2026
Q1
$3.18M Sell
9,051
-390
-4% -$139K 0.37% 51
2025
Q4
$3.09M Sell
9,441
-54
-0.6% -$17.1K 0.36% 58
2025
Q3
$2.68M Sell
9,495
-408
-4% -$118K 0.31% 62
2025
Q2
$2.76M Sell
9,903
-785
-7% -$222K 0.35% 58
2025
Q1
$3.33M Sell
10,688
-235
-2% -$69.4K 0.41% 51
2024
Q4
$2.85M Sell
10,923
-677
-6% -$201K 0.37% 55
2024
Q3
$3.74M Buy
+11,600
New +$3.79M 0.46% 49

Other funds holding AMGN

Philip James Wealth Mangement's AMGN Position: Q2 2026 in Review

Philip James Wealth Mangement reduced its Amgen (AMGN) stake by 1.1% in Q2 2026, selling an estimated $35.3K and leaving 8,948 shares worth $3.24M. The position accounts for 0.36% of the portfolio, ranked #56.

Philip James Wealth Mangement first reported a position in AMGN in Q3 2024 and has held it in 8 quarters since. The position peaked at $3.74M in Q3 2024. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Philip James Wealth Mangement held 8,948 shares of Amgen worth $3.24M as of Q2 2026.
  • Philip James Wealth Mangement sold 103 Amgen shares in Q2 2026, an estimated $35.3K.
  • Amgen made up 0.36% of Philip James Wealth Mangement's portfolio in Q2 2026, its #56 holding.
  • Philip James Wealth Mangement first reported a position in Amgen in Q3 2024 and has held it in 8 quarters since.
  • Philip James Wealth Mangement's Amgen position peaked at $3.74M in Q3 2024.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Philip James Wealth Mangement's 13F filing for Q2 2026, filed 27 Jul 2026.